Diginex Acquires The Remedy Project to Bolster ESG and Supply Chain Solutions
summarizeSummary
Diginex's acquisition of The Remedy Project significantly enhances its ESG and supply chain technology offerings by integrating specialized human rights due diligence and remediation expertise. This strategic move positions Diginex to capitalize on growing global demand for ethical supply chain management and compliance with evolving regulations like the EU Corporate Sustainability Due Diligence Directive. The deal involves a notable share issuance, with further shares contingent on future performance, indicating a growth-oriented acquisition.
check_boxKey Events
-
Strategic Acquisition Closed
Diginex acquired 100% of The Remedy Project Limited, a Hong Kong-based ESG advisory company specializing in human rights due diligence and worker rights.
-
Consideration Details
The initial payment involved the issuance of 1,000,000 Diginex ordinary shares, valued at $3.79 million ($3.79 per share) at the time of the transaction.
-
Performance-Based Earn-Out
Up to an additional 1,000,000 Diginex ordinary shares are contingent on The Remedy Project meeting specific adjusted EBITDA targets over the next three years.
-
Enhanced ESG Offerings
The acquisition combines Diginex's advanced supply chain technology with The Remedy Project's expertise, creating a comprehensive ecosystem for businesses to achieve resilient, ethical operations and comply with global ESG regulations.
auto_awesomeAnalysis
Diginex's acquisition of The Remedy Project significantly enhances its ESG and supply chain technology offerings by integrating specialized human rights due diligence and remediation expertise. This strategic move positions Diginex to capitalize on growing global demand for ethical supply chain management and compliance with evolving regulations like the EU Corporate Sustainability Due Diligence Directive. The deal involves a notable share issuance, with further shares contingent on future performance, indicating a growth-oriented acquisition.
在该文件披露时，DGNX的交易价格为$2.72，交易所为NASDAQ，所属行业为Technology，市值约为$5.4亿。 52周交易区间为$0.45至$39.85。 这份文件被评估为积极市场情绪，重要性评分为8/10。